News Focus
News Focus
icon url

runncoach

06/18/21 7:33 AM

#1856 RE: HANUMAN #1855

I thought it was stated somewhere that they would be reported on at the AAIC meeting late next month. Not sure if it was in a PR or conference or on one of the seeking alpha blogs that report incorrect information at times. I don't have time to look at the moment but that was my understanding. I could be wrong
icon url

ranchhand71

06/18/21 9:54 AM

#1857 RE: HANUMAN #1855

Some reveal during SAVA presentation here and when:
https://www.alz.org/aaic/overview.asp
icon url

runncoach

06/19/21 11:44 AM

#1859 RE: HANUMAN #1855

Finally had time to look Hanuman. This is from their June corporate slides.

• July 2021: announcement of clinical results on safety & cognition in patients
who’ve completed at least 9 months of open-label treatment with simufilam.
• New dataset will be presented July 29th at the 2021 Alzheimer’s Association International
Conference (AAIC) in Denver.
• AAIC’s scientific committee has invited the Company’s scientists to present the dataset as an
oral presentation.
• Sept 2021: announcement of clinical results on safety & cognition in patients
who’ve completed at least 12 months of open-label treatment with simufilam.